Elos Medtech AB (publ) announced that Tina Friis-Poulsen has been appointed to succeed Soren Olesen in leading Elos Medtech in Gorlose, Denmark. Tina Friis-Poulsen has been with the company for more than 10 years as Quality and Regulatory Manager and has previously also been leading and responsible for Group QA/RA. Soren Olesen will be handing over responsibility to Tina Friis-Poulsen. Soren Olesen will retain his Dental Business Director role with more focus on, among other things, strategic business development within Elos Medtech and continue reporting to CEO Jan Wahlström. The transition of site leadership responsibilities will be implemented during the first quarter of 2021. Tina Friis-Poulsen will officially assume the position of Managing Director on April 1, 2021.